It's past time for everyone to lose interest in what Dr T may or may not think.
Dr T put RAC off to a great start with a string of successful preclinicals.
RAC is under new management now.
DCB has achieved a lot during his short time at RAC.
e.g. the agreement with COH removes the fear that BP would have had about a potential patent dispute. That's a critical step towards finding a partner.
DCB wants to get the drug to patients asap.
So should everyone.
Disclosure: I don't care if RAC gets sold off for less than Hunterr's price.
Ann: Race Strategic Update August 2023, page-368
-
- There are more pages in this discussion • 225 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $267.6M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |